09/03/2019 | |
Cancer immunotherapy has emerged as a powerful tool in cancer treatment. The key insight was that a patient’s own immune system could be harnessed to recognize and destroy cancer cells. Allen joined a phase 1 trial at the NIH Clinical Center, one of several sites testing a combination of rituximab (Rituxan) with Hu5F9-G4, a monoclonal antibody that blocks the CD47 protein on tumor cells. This treatment exposes tumor cells to destruction by the immune system. |
viernes, 6 de septiembre de 2019
Immune System and Cancer: Image Details - NCI Visuals Online
Immune System and Cancer: Image Details - NCI Visuals Online
![National Cancer Institute](https://blogger.googleusercontent.com/img/proxy/AVvXsEjd-8HX2YmrRQW80SEOsyPk7qfCmtmnZ0titlo4ZroKlv8HoVKBPpCDkIXhGs86Z3YESTdohxCNYF4XpGOx5sKQqGwRJnj44Pj6UE3Sg3UyM_7s4zaO_LKyIkg6ziluXH34Bf6kbFQTzNfi4JRkLtvi2w6y-Ly5BBH7-Oj8p46bVueuF_tcKi8GAK57sAO0mInS9bQ3QPXhyphenhyphenUKwg6ydmp4nQTMBuoVCokVzsg0cjxeZ3k8=s0-d-e1-ft)
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario